VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.104677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Zi-Qi Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation…. Hauptthemen laut MEDLINE: Carcinogenesis, E2F7 Transcription Factor, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, National Natural Science Foundation of China, Health Medical Collaborative Innovation Program of Guangzhou.
Abstract (Originalsprache)
The N6-methyladenosine (m6A) modification possesses new and essential roles in tumor initiation and progression by regulating mRNA biology. However, the role of aberrant m6A regulation in nasopharyngeal carcinoma (NPC) remains unclear. Here, through comprehensive analyses of NPC cohorts from the GEO database and our internal cohort, we identified that VIRMA, an m6A writer, is significantly upregulated in NPC and plays an essential role in tumorigenesis and metastasis of NPC, both in vitro and in vivo. High VIRMA expression served as a prognostic biomarker and was associated with poor outcomes in patients with NPC. Mechanistically, VIRMA mediated the m6A methylation of E2F7 3'-UTR, then IGF2BP2 bound, and maintained the stability of E2F7 mRNA. An integrative high-throughput sequencing approach revealed that E2F7 drives a unique transcriptome distinct from the classical E2F family in NPC, which functioned as an oncogenic transcriptional activator. E2F7 cooperated with CBFB-recruited RUNX1 in a non-canonical manner to transactivate ITGA2, ITGA5, and NTRK1, strengthening Akt signaling-induced tumor-promoting effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guan…
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- National Natural Science Foundation of China
- Health Medical Collaborative Innovation Program of Guangzhou
- Ministry of Education of the People's Republic of China
- Sun Yat-sen University Cancer Center
- China Postdoctoral Science Foundation
- Postdoctoral Research Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zheng, Z. Q., Huang, Z. H., Liang, Y. L., Zheng, W. H., Xu, C., Li, Z. X., Liu, N., Yang, P. Y., Li, Y. Q., Ma, J., Sun, Y., Tang, L. L., & Wei, D. (2023). VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104677
Vancouver
Zheng ZQ, Huang ZH, Liang YL, Zheng WH, Xu C, Li ZX, et al. VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104677
BibTeX
@article{Zheng2023,
author = {Zheng, Zi-Qi and Huang, Zhuo-Hui and Liang, Ye-Lin and Zheng, Wei-Hong and Xu, Cheng and Li, Zhi-Xuan and Liu, Na and Yang, Pan-Yang and Li, Ying-Qin and Ma, Jun and Sun, Ying and Tang, Ling-Long and Wei, Denghui},
title = {VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.104677}
}
EUVIMED